AmgenAMGN.OValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Richly Valued” zone.
As of Oct 16, 2026, Amgen (AMGN.O) trades at a P/E of 26.70x, P/B of 20.00x, P/S of 6.14x, and a dividend yield of 1.74%.
Longitudinal percentile comparison: P/E sits at the 79th percentile over the trailing 10Y window (vs. 64th percentile over 3Y); P/B sits at the 64th percentile over the trailing 10Y window (vs. 29th percentile over 3Y); P/S sits at the 99th percentile over the trailing 10Y window (vs. 99th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 54th percentile within its industry and the 65th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 1.74%, ranking at the 0th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 15.3 points — relying on either metric alone could be misleading. Relative to industry peers, its P/E shows a deeper discount than it does against the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Amgen operates in the Manufacturing sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NASDAQ: AMGN · AMGN
Want the full picture on whether Amgen (AMGN.O) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 26.70 | ||||||
| P/B (MRQ) | 20.00 | ||||||
| P/S (TTM) | 6.14 | ||||||
| Dividend Yield | 1.74% | ||||||
| Buyback + Div Yield | 1.74% |